No experience
Employment Type:
Full time
Job Category:
Health Care Provider
Field Excellence Coach, Multiple Sclerosis Medical Science Liaisons-Central
(This job is no longer available)
Biogen | Weston, MA
Grad Date

Not sure what types of jobs you are interested in?

Explore Jobs
Based on Your Education

Follow This Company

Job Description

External Posting TitleField Excellence Coach, Multiple Sclerosis Medical Science Liaisons-Central
Job DescriptionThis is a field based role that will cover the Central United States

The field excellence coach is responsible, in cooperation with the Regional Field Director, for the individual professional development of the MSL's and for the pull through of trainings performed by the global medical training department.
The coach will assume as primary mentor to new hires and will direct and deliver the field training plan. The field coach will use a strengths based coaching lens to identify and share best practices with MSL's in the field to further the performance of the team and the development of its individual. The field coach is responsible for understanding the collective skill level of the MSL organization through frequent field exposure. The field coach should been seen by the MSL team as a positive force for growth and development and as a partner in promoting field excellence. Field coaches will work collaboratively with Regional and National director(s) to develop long term outage plans in order to ensure appropriate proactive and reactive presence in all territories. .
Principle accountabilities will include:
-Develop and maintain MSL development plans.
-Develop and execute on new hire mentor plans.
-Develop and execute on long term coverage plans.
-Work with global training to maintain an accurate assessment of organizational skills and to pull through global medical trainings into the field.
-Support the global learning function by providing a national assessment of needs and through strategizing on plans for future learnings.
LocationWeston, MA, US
Job CategoryGlobal Medical/Medical Affairs
Requisition Number30981BR
Qualifications7+years of field medical experience

Must be 18 years of age or older with Valid Driver's License and an acceptable driving record.

Must have authorization and ability to drive a Company leased vehicle or rental

This role is a field based position and the ideal candidate must be able to travel 60-70% of the time, including ability to travel overnight and occasionally on weekends.

Qualified candidates will be proficient in the following leadership competencies:
-Personal Drive, Decision Making, Communication, Building Strategic Work Relationships, Developing people and Innovation
The role requires the following skills/behaviors:
- Presentation & Coaching Skills, Focus on priorities / sense of urgency, Accountability, Collaboration & Teamwork, Mutual respect, Trust and Integrity.
Finally, the Field Excellence Coaches should be recognized by the field team as a positive force for growth and development and as a partner in promoting field excellence. He/she must demonstrate a solid Scientific, Business, and Compliance Knowledge and be able to manage projects on an ad hoc basis.

Strong team leadership, collaboration and management skills. A proven track record of field based medical excellence. Strong coaching experience or positive attitude and mentoring experience as an MSL. Experience and knowledge in the following areas are important: Field medical skills &competencies; field medical soft skills; medical business knowledge, field compliance knowledge, HEOR knowledge a strong preference.
EducationPh.D. in a biological science or related field, Pharm.D., Nurse Practitioner or MD
About BiogenThrough cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy and is at the forefront of neurology research for conditions including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics.

With more than 7,000 people worldwide, Biogen is truly a global organization. We are headquartered in Cambridge, Massachusetts, which is home to our research operations. Our international operations are based in Zug, Switzerland and we have world-class manufacturing facilities in North Carolina and Denmark. With a strong affiliate presence and a network of distribution partners, Biogen has established a global footprint that allows us to capture the greatest value for the products we develop.

All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.

Please be advised that all legitimate correspondence from a Biogen employee will come from "@biogen.com" email accounts.

About Biogen

Biogen Idec Inc. is engaged in the development, manufacturing, and commercialization of therapies. The Company's products address diseases such as multiple sclerosis, lymphoma and rheumatoid arthritis. The Company has four products: AVONEX (interferon beta-1a), RITUXAN (rituximab), TYSABRI (natalizumab) and FUMADERM (dimethylfumarate and monoethylfumarate salts). AVONEX is used in the treatment of relapsing forms of multiple sclerosis (MS). RITUXAN is used in the treatment of relapsed or refractory low-grade or follicular, CD20-positive, and B-cell, non-Hodgkin's lymphomas (B-cell NHLs). TYSABRI is approved for the treatment of relapsing forms of MS. FUMADERM acts as an immunomudulator. It also has product candidates, such as BG-12 (acquired with the purchase of Fumapharm), ANTI-CD80 antibody/(galiximab), ANTI-CD23 antibody/(lumiliximab), Ocrelizumab/(Humanized ANTI-CD20 Antibody) and Lixivaptan.In January 2007, the Company completed the acquisition of Syntonix Pharmaceuticals, Inc. (Source: 10-K)